Imunon, Inc.
IMNN
$1.59
$0.085.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 3.80M | 3.56M | 3.39M | 3.39M | 3.39M |
| Gross Profit | -3.80M | -3.56M | -3.39M | -3.39M | -3.39M |
| SG&A Expenses | 6.65M | 6.86M | 6.87M | 7.01M | 7.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.84M | 14.81M | 14.65M | 14.54M | 16.02M |
| Operating Income | -14.84M | -14.81M | -14.65M | -14.54M | -16.02M |
| Income Before Tax | -14.72M | -14.64M | -14.50M | -14.33M | -15.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.72 | -14.64 | -14.50 | -14.33 | -15.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.72M | -14.64M | -14.50M | -14.33M | -15.75M |
| EBIT | -14.84M | -14.81M | -14.65M | -14.54M | -16.02M |
| EBITDA | -14.55M | -14.52M | -14.36M | -14.28M | -15.78M |
| EPS Basic | -3.99 | -5.60 | -7.91 | -9.58 | -12.17 |
| Normalized Basic EPS | -2.49 | -3.50 | -4.94 | -5.99 | -7.60 |
| EPS Diluted | -3.99 | -5.60 | -7.91 | -9.58 | -12.17 |
| Normalized Diluted EPS | -2.49 | -3.50 | -4.94 | -5.99 | -7.60 |
| Average Basic Shares Outstanding | 16.13M | 12.18M | 8.45M | 6.83M | 5.17M |
| Average Diluted Shares Outstanding | 16.13M | 12.18M | 8.45M | 6.83M | 5.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |